ロード中...
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
BACKGROUND: Schizophrenia is a highly heterogeneous disorder, and around a third of patients are treatment-resistant. The only evidence-based treatment for these patients is clozapine, an atypical antipsychotic with relatively weak dopamine antagonism. It is plausible that varying degrees of respons...
保存先:
| 出版年: | BMC Psychiatry |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237235/ https://ncbi.nlm.nih.gov/pubmed/28086761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-016-1177-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|